Liva Checkmahomed

Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains

Liva Checkmahomed, Zeineb Mhamdi, Julie Carbonneau et al. · The Journal of Infectious Diseases · 2019 · 61 citations · Full text

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses

Liva Checkmahomed, Blandine Padey, Andrés Pizzorno et al. · Viruses · 2020 · 37 citations · Full text

Other Inhibitors, Antiviral Compound, Medicine +14

<i>In Vitro</i> Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance

Liva Checkmahomed, Julie Carbonneau, Venice Du Pont et al. · Antimicrobial Agents and Chemotherapy · 2022 · 36 citations · Full text

Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice

Yacine Abed, Clément Fage, Liva Checkmahomed et al. · Antiviral Research · 2020 · 19 citations

Vaccination, Viral Evolution, Pathogenesis +9

A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice

Hugues Fausther‐Bovendo, Marie‐Ève Hamelin, Julie Carbonneau et al. · Biomedicines · 2022 · 12 citations · Full text

Viral Replication, Molecular Virology, Allergy +13